Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TRAILOKYA PANDIT

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1538329560
CMS profile
890662
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,539.10

157 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,402.97 154
Education $136.13 3

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $350.08 14
PFIZER INC. $286.66 14
Merck Sharp & Dohme LLC $264.44 12
GENZYME CORPORATION $262.79 10
Daiichi Sankyo Inc. $232.24 11
GlaxoSmithKline, LLC. $154.01 8
Exelixis Inc. $148.85 8
Janssen Biotech, Inc. $142.76 7
Eisai Inc. $125.25 6
ARRAY BIOPHARMA INC $123.37 9
SEAGEN INC. $99.99 1
Genentech USA, Inc. $88.07 4
ABBVIE INC. $84.12 4
Bayer Healthcare Pharmaceuticals Inc. $83.13 3
BeOne Medicines USA, Inc. $70.40 3
Takeda Pharmaceuticals U.S.A., Inc. $70.16 2
JAZZ PHARMACEUTICALS INC. $61.56 2
Caris MPI, Inc. $59.62 2
EMD Serono, Inc. $59.59 2
Karyopharm Therapeutics Inc. $48.63 2
Adaptive Biotechnologies Corporation $45.14 2
Deciphera Pharmaceuticals Inc. $44.70 2
Legend Biotech USA Inc. $42.99 2
Novartis Pharmaceuticals Corporation $42.58 2
AVYXA PHARMA, LLC $39.31 2
Acrotech Biopharma Inc. $36.58 2
Ethicon US, LLC $34.99 1
Invivyd Inc $31.71 1
PUMA BIOTECHNOLOGY, INC. $28.69 1
Astellas Pharma US Inc $27.03 1
Iovance Biotherapeutics, Inc. $26.32 1
Aveo Pharmaceuticals, Inc. $26.13 1
Lilly USA, LLC $26.09 1
Regeneron Healthcare Solutions, Inc. $26.00 1
Dendreon Pharmaceuticals LLC $24.62 1
SpringWorks Therapeutics, Inc. $21.39 1
Alexion Pharmaceuticals, Inc. $20.33 1
CSL Behring $20.33 1
KYOWA KIRIN, INC. $19.62 1
Aimmune Therapeutics, Inc. $19.06 1
ADC THERAPEUTICS AMERICA, INC. $18.54 1
Sumitomo Pharma America, Inc. $17.74 1
Pharmacosmos Therapeutics Inc. $17.43 1
Agios Pharmaceuticals, Inc. $17.17 1
Incyte Corporation $17.10 1
Coherus Oncology, Inc. $15.92 1
Fresenius Kabi USA, LLC $15.87 1

Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TRAILOKYA PANDIT

NPI 1538329560 · CMS profile ID 890662

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538329560?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TRAILOKYA PANDIT, NPI 1538329560, CMS profile ID 890662. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538329560?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). TRAILOKYA PANDIT, NPI 1538329560, CMS profile ID 890662. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538329560?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
TRAILOKYA PANDIT, NPI 1538329560, CMS profile ID 890662, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1538329560?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

157 matching records · $3,539.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 157 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 157.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ARRAY BIOPHARMA INC $24.6809/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230474754 CMS
Eisai Inc. $20.0608/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244517057 CMS
Legend Biotech USA Inc. $20.5308/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236480714 CMS
Novartis Pharmaceuticals Corporation $20.9708/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200713281 CMS
Merck Sharp & Dohme LLC $13.0708/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238072943 CMS
AstraZeneca Pharmaceuticals LP $27.5408/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207008977 CMS
Daiichi Sankyo Inc. $27.8208/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197019683 CMS
Merck Sharp & Dohme LLC $21.8308/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238013930 CMS
AstraZeneca Pharmaceuticals LP $28.4308/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207018072 CMS
Daiichi Sankyo Inc. $27.4808/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197014819 CMS
Iovance Biotherapeutics, Inc. $26.3208/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251397015 CMS
GlaxoSmithKline, LLC. $22.3208/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191379040 CMS
GENZYME CORPORATION $39.8708/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233498807 CMS
BeOne Medicines USA, Inc. $22.0708/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202900828 CMS
EMD Serono, Inc. $35.5108/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236870089 CMS
Bayer Healthcare Pharmaceuticals Inc. $29.6808/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225682874 CMS
Janssen Biotech, Inc. $24.2008/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175342369 CMS
Eisai Inc. $15.0607/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244517055 CMS
Lilly USA, LLC $26.0907/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187052199 CMS
GlaxoSmithKline, LLC. $15.5307/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190624506 CMS
ABBVIE INC. $16.2307/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203448355 CMS
Dendreon Pharmaceuticals LLC $24.6207/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245007880 CMS
GENZYME CORPORATION $29.6407/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233498825 CMS
Alexion Pharmaceuticals, Inc. $20.3307/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202926470 CMS
Merck Sharp & Dohme LLC $21.6707/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238072969 CMS
AstraZeneca Pharmaceuticals LP $24.4407/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206803468 CMS
AVYXA PHARMA, LLC $21.2107/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240102525 CMS
Genentech USA, Inc. $23.2607/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211602495 CMS
GlaxoSmithKline, LLC. $15.5307/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191583059 CMS
SEAGEN INC. $99.9907/14/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1229550116 CMS
Exelixis Inc. $31.3507/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218806819 CMS
AstraZeneca Pharmaceuticals LP $13.2007/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206159746 CMS
PFIZER INC. $24.7207/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229465945 CMS
Fresenius Kabi USA, LLC $15.8707/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250534854 CMS
Eisai Inc. $18.8906/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244517053 CMS
PUMA BIOTECHNOLOGY, INC. $28.6906/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251744700 CMS
GENZYME CORPORATION $25.6806/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233498787 CMS
AstraZeneca Pharmaceuticals LP $23.1006/20/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1206180736 CMS
AstraZeneca Pharmaceuticals LP $29.7206/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206241402 CMS
Daiichi Sankyo Inc. $17.4206/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197078571 CMS
JAZZ PHARMACEUTICALS INC. $22.8506/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234332765 CMS
AstraZeneca Pharmaceuticals LP $24.2206/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207243547 CMS
PFIZER INC. $29.7606/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229130227 CMS
ABBVIE INC. $20.2606/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203448349 CMS
Adaptive Biotechnologies Corporation $22.0006/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254935260 CMS
Caris MPI, Inc. $27.9706/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234284051 CMS
Agios Pharmaceuticals, Inc. $17.1706/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253244124 CMS
Daiichi Sankyo Inc. $21.0306/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197077965 CMS
AstraZeneca Pharmaceuticals LP $27.5405/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206663976 CMS
Deciphera Pharmaceuticals Inc. $23.3005/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235960655 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,379.72 79
PY2020 $1,271.39 55
PY2021 $693.29 28
PY2022 $746.32 36
PY2023 $2,437.37 100
PY2024 $2,385.55 98
PY2025 $3,539.10 157

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $36,600.00 4
PY2024 Recipient $2,243.25 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $16,800.00 02/18/2025 Non-covered Recipient Entity
PIEDMONT HEALTHCARE INC
A PHASE 3, OPEN LABEL, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, IN COMBINATION WITH CHOP (O-CHOP) VERSUS RITUXIMAB IN COMBINATION WITH CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PARTICIPANTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (OLYMPIA-3) No dispute reported 06/30/2026 1184154372
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,500.00 02/18/2025 Non-covered Recipient Entity
PIEDMONT HEALTHCARE INC
A PHASE 3, OPEN LABEL, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, IN COMBINATION WITH CHOP (O-CHOP) VERSUS RITUXIMAB IN COMBINATION WITH CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PARTICIPANTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (OLYMPIA-3) No dispute reported 06/30/2026 1184154374
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $16,800.00 02/13/2025 Non-covered Recipient Entity
PIEDMONT HEALTHCARE INC
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20X ANTI-CD3 BISPECIFIC ANTIBODY, COMBINED WITH CHEMOTHERAPY VERSUS RITUXIMAB COMBINED WITH CHEMOTHERAPY IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-2) No dispute reported 06/30/2026 1184153934
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,500.00 02/13/2025 Non-covered Recipient Entity
PIEDMONT HEALTHCARE INC
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20X ANTI-CD3 BISPECIFIC ANTIBODY, COMBINED WITH CHEMOTHERAPY VERSUS RITUXIMAB COMBINED WITH CHEMOTHERAPY IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-2) No dispute reported 06/30/2026 1184153936